62 related articles for article (PubMed ID: 9865917)
21. Effects of socioeconomic and geographic variations on survival for adult glioma in England and Wales.
Tseng JH; Merchant E; Tseng MY
Surg Neurol; 2006 Sep; 66(3):258-63; discussion 263. PubMed ID: 16935629
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
[TBL] [Abstract][Full Text] [Related]
23. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma.
Cloos J; Leemans CR; van der Sterre ML; Kuik DJ; Snow GB; Braakhuis BJ
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):713-7. PubMed ID: 10919742
[TBL] [Abstract][Full Text] [Related]
24. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
[TBL] [Abstract][Full Text] [Related]
26. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
27. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
[TBL] [Abstract][Full Text] [Related]
28. High-grade gliomas in patients with prior systemic malignancies.
Maluf FC; DeAngelis LM; Raizer JJ; Abrey LE
Cancer; 2002 Jun; 94(12):3219-24. PubMed ID: 12115354
[TBL] [Abstract][Full Text] [Related]
29. Debulking or biopsy of malignant glioma in elderly people - a randomised study.
Vuorinen V; Hinkka S; Färkkilä M; Jääskeläinen J
Acta Neurochir (Wien); 2003 Jan; 145(1):5-10. PubMed ID: 12545256
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms.
Ruffini E; Asioli S; Filosso PL; Lyberis P; Bruna MC; Macrì L; Daniele L; Oliaro A
Ann Thorac Surg; 2009 Feb; 87(2):365-71; discussion 371-2. PubMed ID: 19161739
[TBL] [Abstract][Full Text] [Related]
32. [Prognosis of gliomas].
Loiseau H
Rev Neurol (Paris); 1996 Feb; 152(2):84-102. PubMed ID: 8761615
[TBL] [Abstract][Full Text] [Related]
33. gamma-Radiation-induced chromosomal mutagen sensitivity is associated with breast cancer risk in African-American women: caffeine modulates the outcome of mutagen sensitivity assay.
Natarajan TG; Ganesan N; Carter-Nolan P; Tucker CA; Shields PG; Adams-Campbell LL
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):437-42. PubMed ID: 16537698
[TBL] [Abstract][Full Text] [Related]
34. Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.
Liu Y; Shete S; Wang LE; El-Zein R; Etzel CJ; Liang FW; Armstrong G; Tsavachidis S; Gilbert MR; Aldape KD; Xing J; Wu X; Wei Q; Bondy ML
Carcinogenesis; 2010 Oct; 31(10):1762-9. PubMed ID: 20610542
[TBL] [Abstract][Full Text] [Related]
35. [Malignant brain tumor].
Nomura K
No To Shinkei; 1996 May; 48(5):403-8. PubMed ID: 8672297
[No Abstract] [Full Text] [Related]
36. Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma.
Derks J; Wesseling P; Carbo EWS; Hillebrand A; van Dellen E; de Witt Hamer PC; Klein M; Schenk GJ; Geurts JJG; Reijneveld JC; Douw L
J Neurooncol; 2018 Nov; 140(2):403-412. PubMed ID: 30094719
[TBL] [Abstract][Full Text] [Related]
37. Radiation-induced chromatid breaks as a predictor of breast cancer risk.
Buchholz TA; Wu X
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):533-7. PubMed ID: 11173151
[TBL] [Abstract][Full Text] [Related]
38. Risk assessment for developing gliomas: a comparison of two cytogenetic approaches.
El-Zein R; Bondy ML; Wang LE; de Andrade M; Sigurdson AJ; Bruner JM; Kyritsis AP; Levin VA; Wei Q
Mutat Res; 2001 Jan; 490(1):35-44. PubMed ID: 11152970
[TBL] [Abstract][Full Text] [Related]
39. Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case-control study.
Wang LE; Han CH; Xiong P; Bondy ML; Yu TK; Brewster AM; Shete S; Arun BK; Buchholz TA; Wei Q
Breast Cancer Res Treat; 2012 Apr; 132(3):1147-55. PubMed ID: 22218884
[TBL] [Abstract][Full Text] [Related]
40. Cryopreserving whole blood for functional assays using viable lymphocytes in molecular epidemiology studies.
Cheng L; Wang LE; Spitz MR; Wei Q
Cancer Lett; 2001 May; 166(2):155-63. PubMed ID: 11311488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
